CME Group Inc. (NASDAQ:CME) Shares Purchased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. raised its stake in shares of CME Group Inc. (NASDAQ:CMEGet Rating) by 72.2% during the 1st quarter, Holdings Channel reports. The institutional investor owned 73,486 shares of the financial services provider’s stock after buying an additional 30,812 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in CME Group were worth $17,479,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of CME. Power Corp of Canada acquired a new position in shares of CME Group in the 1st quarter worth approximately $26,000. Bromfield Sneider Wealth Advisors acquired a new position in shares of CME Group in the 1st quarter worth approximately $26,000. IndexIQ Advisors LLC acquired a new position in shares of CME Group in the 1st quarter worth approximately $27,000. Cornerstone Advisory LLC acquired a new position in shares of CME Group in the 4th quarter worth approximately $29,000. Finally, MayTech Global Investments LLC acquired a new position in shares of CME Group in the 1st quarter worth approximately $36,000. Institutional investors and hedge funds own 85.56% of the company’s stock.

Insider Buying and Selling at CME Group

In other CME Group news, insider Ken Vroman sold 750 shares of CME Group stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $201.41, for a total value of $151,057.50. Following the completion of the sale, the insider now directly owns 12,486 shares in the company, valued at $2,514,805.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Ken Vroman sold 750 shares of CME Group stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $201.41, for a total value of $151,057.50. Following the transaction, the insider now owns 12,486 shares of the company’s stock, valued at $2,514,805.26. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Derek Sammann sold 4,000 shares of CME Group stock in a transaction that occurred on Friday, September 9th. The shares were sold at an average price of $201.51, for a total transaction of $806,040.00. Following the completion of the transaction, the insider now directly owns 13,333 shares in the company, valued at approximately $2,686,732.83. The disclosure for this sale can be found here. Insiders sold 10,151 shares of company stock worth $2,054,508 over the last ninety days. 0.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CME shares. Credit Suisse Group lowered their price objective on shares of CME Group from $216.00 to $210.00 and set a “neutral” rating on the stock in a research note on Tuesday, September 6th. Morgan Stanley decreased their target price on shares of CME Group from $242.00 to $226.00 and set an “equal weight” rating for the company in a report on Thursday, July 28th. Atlantic Securities upgraded shares of CME Group from a “neutral” rating to an “overweight” rating and set a $235.00 target price for the company in a report on Friday, June 10th. Oppenheimer upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $223.00 target price for the company in a report on Wednesday, May 25th. Finally, Rosenblatt Securities initiated coverage on shares of CME Group in a report on Tuesday, August 16th. They issued a “sell” rating and a $171.00 target price for the company. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $230.80.

CME Group Stock Performance

CME stock opened at $191.56 on Monday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $68.85 billion, a P/E ratio of 23.77, a P/E/G ratio of 3.09 and a beta of 0.40. The firm has a 50 day simple moving average of $199.93 and a 200 day simple moving average of $211.82. CME Group Inc. has a 52 week low of $185.79 and a 52 week high of $256.94.

CME Group (NASDAQ:CMEGet Rating) last posted its earnings results on Wednesday, July 27th. The financial services provider reported $1.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.05. The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.25 billion. CME Group had a net margin of 60.43% and a return on equity of 9.65%. The company’s revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the company earned $1.64 earnings per share. Research analysts anticipate that CME Group Inc. will post 7.96 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 27th. Shareholders of record on Friday, September 9th will be paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 2.09%. The ex-dividend date is Thursday, September 8th. CME Group’s dividend payout ratio (DPR) is presently 49.63%.

CME Group Company Profile

(Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEGet Rating).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.